Company intelligence / Profile preview

Shanghai ZJ Bio-Tech

Shanghai, Shanghai, Chinam.liferiver.com.cn ↗

Ownership: Private
Employees: ~305
Development stage: Other

Overview

Shanghai ZJ Bio-Tech has developed over 200 rapid gene diagnostic products covering a wide range of infectious diseases. Their real-time fluorescence PCR kits are widely used in clinical diagnostics and public health emergencies. Several products have received SFDA certification. The company’s COVID‑19 RT-PCR kit was among the first to market during the pandemic.

Therapeutic areas: Infectious Diseases
Modalities: Nucleic acid diagnostic reagents (including PCR-based kits)Molecular diagnostic instruments
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Shanghai ZJ Bio-Tech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai ZJ Bio-Tech.

Explore the full profile